stockrow
Friday 6 November 2026
Export FRNM’s income statement to Excel — free account
Freenome, Inc
FRNM Healthcare Diagnostics & Research
- EPS
- −115.2%
- Free cash flow
- +12.1%
Quarter to June 2026, against a year earlier
10.15
0.32
−3.06%
Follow FRNM
Alert me
| Dec '24 | Dec '25 | |
|---|---|---|
Current Ratio |
5.90 | 0.40 |
Net Debt/EBITDA |
2.29 | 0.29 |
Debt/Assets |
0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 |
Asset Turnover |
— | 0.00 |
Operating CF/Net income |
(0.19) | (1.03) |
| 0.00% | (24.23%) | |
| 0.00% | 0.92% | |
ROIC |
0.00% | 0.00% |
Return on Tangible Assets |
184.78% | (62.19%) |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 |
Free Cash Flow per Share |
(0.16) | (0.35) |
Cash per Share |
0.50 | 0.35 |
Shareholders Equity per Share |
(0.94) | (1.96) |
Interest Debt per Share |
0.00 | 0.00 |
Book value per Share |
(0.94) | (1.96) |
Free Cash Flow |
(0.35) | (0.86) |
Working Capital |
1.03 | (1.35) |
Net Current Asset Value |
(90.77) | (96.67) |
| Other line items | ||
Quick Ratio |
5.36 | 0.38 |
Cash ROIC |
35.85% | 21.99% |
Revenue per Share |
0.00 | 0.00 |
Operating CF per Share |
(0.16) | (0.35) |
Capex per Share |
0.00 | 0.00 |
Average Assets |
— | 91.34 |
Average Common Equity |
— | (3.46) |
Columns are period end dates